Navigation Links
Bacterial communication encourages chronic, resistant ear infections
Date:7/6/2010

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio, the online open-access journal of the American Society for Microbiology.

"In this study we show that communication between bacterial species promotes bacterial persistence and resistance to antibiotics, which are important considerations in the diagnosis, preventions and treatment of otitis media (OM)," says W. Edward Swords, an associate professor of microbiology and immunology and senior author of the study. Chelsie Armbruster, a Ph.D. student working in Swords' lab, co-authored the study.

OM is one of the most common childhood infections and is the leading reason for pediatric office visits and new antibiotic prescriptions to children. OM infections often persist for long periods of time and are often resistant to antibiotics. These chronic and recurrent cases of OM involve the persistence of the bacteria within a biofilm community, a state in which they are highly resistant to both natural clearance by the immune system and antibiotic treatment.

Epidemiological data indicate that the majority of chronic OM infections are polymicrobial in nature, meaning they are caused by more than one species of bacteria. Haemophilus influenzae and Moraxella catarrhalis are frequently found together in samples obtained from patients with chronic and recurrent OM.

"Interestingly, a recent study found M. catarrhalis to be more frequently associated with polymicrobial OM infections than from single-species OM infections. This suggests that the presence of other bacterial pathogens may impact the persistence of M. catarrhalis or the severity of disease caused by this species," says Swords.

In examining the dynamics between these two bacteria in culture and animal models, Swords and his colleagues discovered the H. influenzae secreted autoinducer-2 (AI-2), a chemical involved in an interbacterial method of communication known as quorum sensing, that promoted increased biofilm formation and antibiotic resistance in M. catarrhalis.

"We conclude that H. influenzae promotes M. catarrhalis persistence within polymicrobial infection biofilms via inter-species quorum signaling. AI-2 may therefore represent an ideal target for disruption of chronic polymicrobial infections," says Swords. "Moreover, these results strongly imply that successful vaccination against the unencapsulated H. influenzae strains that cause airway infections may also significantly impact chronic M. catarrhalis disease by removing a reservoir for the AI-2 signal that promotes M. catarrhalis persistence within biofilms."


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Related medicine news :

1. FDA to Re-examine Anti-Bacterial Chemical in Soaps, Cleansers
2. Bacterial phylotype alterations in irritable bowel syndrome
3. Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities
4. Mayo Clinic Proceedings: Gabapentin opens window of communication
5. Online Housecalls, Improved Patient Care and Increased Communication Between Doctors and Healthcare Professionals Now Made Possible Through Docgreet.com
6. NTUs Wee Kim Wee School of Communication to host International Communication Association Conference
7. Communication Program Didnt Improve Autism Symptoms
8. iPBX Hosted Communications Service from DSCI Now Includes Bria Softphone
9. Salesforce.com Users Increase Sales and Marketing Communications 320 Percent
10. First Communications, Inc. Announces Audited Results for the Year Ended December 31, 2009
11. Esna Technologies Receives Unified Communications Magazine's 2009 Product of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: